The brain chip company that has drawn interest from Sam Altman and his artificial intelligence business OpenAI is exploring ...

Sam Altman is reportedly entering in brain-computer interface domain through a new startup, Merge Labs. The company is ...

A novel gene therapy idea is reportedly among the focus areas considered by Merge Labs, a new brain-computer interface ...

OpenAI is reportedly discussing a potential investment in a new startup that aims to compete with Elon Musk’s brain implant ...

Microsoft (NASDAQ:MSFT)-backed OpenAI co-founder Sam Altman is gearing up to back Merge Labs, a new brain-computer interface startup that could go head-to-head with Elon Musk's Neuralink, the ...

Merge Labs is a new Neuralink rival developing brain-computer interfaces. If you’ve enjoyed Elon Musk’s ongoing beef with ...

Merge Labs will compete with Elon Musk’s Neuralink, which is developing computer interface chips designed to be implanted in ...

Sam Altman is preparing to co-found a new company funded by OpenAI that will go up against Elon Musk's Neuralink.

The rivalry between Sam Altman, CEO of OpenAI, and Tesla’s Elon Musk has taken on a new dimension as Altman is named a ...

In a strategic move, OpenAI CEO Sam Altman is reportedly planning to invest in a brain implant startup, called Merge Labs, ...

At a dinner with reporters in San Francisco, OpenAI CEO Sam Altman spilled details on the company's ambitions beyond ChatGPT.

OpenAI CEO Sam Altman is in talks to co-found Merge Labs, a potential $850M brain–computer interface startup rivaling Elon ...